Clinical Trial Update: A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial evaluating the efficacy and safety of IBI128 in Chinese patients with gout and hyperuricemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• IBI128

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Gout, Hyperuricemia | Phase 2 | Status: COMPLETED